The effect of exenatide re-exposure on safety and efficacy
- 30 September 2009
- Vol. 30 (9) , 1771-1774
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Efficacy and safety of exenatide in patients of Asian descent with type 2 diabetes inadequately controlled with metformin or metformin and a sulphonylureaDiabetes Research and Clinical Practice, 2009
- Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: A multinational, randomized, open-label, two-period, crossover noninferiority trialClinical Therapeutics, 2007
- The Effect of Adding Exenatide to a Thiazolidinedione in Suboptimally Controlled Type 2 DiabetesAnnals of Internal Medicine, 2007
- Immunogenicity of xenopeptide hormone therapiesPeptides, 2006
- Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a SulfonylureaDiabetes Care, 2005
- Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 DiabetesDiabetes Care, 2005
- Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 DiabetesDiabetes Care, 2004
- World Medical Association Declaration of HelsinkiJAMA, 2000
- Immunogenicity of biosynthetic human insulinDiabetes Research and Clinical Practice, 1986